Abstract
Mechanical ventilation is a life-supporting intervention that is used for a significant number of patients in ICUs. The current pediatric literature shows that the science of ventilator weaning and extubation remains undetermined. No optimal weaning method has been described for a more rapid and successful extubation. Protocol-based approaches to weaning may have potential benefits in advancing readiness to extubation, but no significant outcome differences have been found to date. The analysis of clinical markers of extubation success has not revealed any specific physiologic predictor of extubation success in children. However, a daily trial of readiness to extubate is the most effective technique to determine likelihood of success. Extubation failure rates range from 16% to 20% and bear little relation to the duration of mechanical ventilation. Upper airway obstruction is the primary cause of extubation failure in most pediatric studies. Therefore, efforts to decrease airway edema before extubation should be considered. Corticosteroids seem to be beneficial for infants and children, but definitive evidence of their efficacy is lacking.
Keywords: Extubation, mechanical ventilation, respiratory support, weaning, pediatrics, maximal expiratory pressure, rapid shallow breathing index, respiratory muscle load, hyperthermia, Spontaneous Breathing Trial
Current Respiratory Medicine Reviews
Title: Weaning and Extubation in Pediatrics
Volume: 8 Issue: 1
Author(s): Cintia Johnston and Paulo Sergio Lucas da Silva
Affiliation:
Keywords: Extubation, mechanical ventilation, respiratory support, weaning, pediatrics, maximal expiratory pressure, rapid shallow breathing index, respiratory muscle load, hyperthermia, Spontaneous Breathing Trial
Abstract: Mechanical ventilation is a life-supporting intervention that is used for a significant number of patients in ICUs. The current pediatric literature shows that the science of ventilator weaning and extubation remains undetermined. No optimal weaning method has been described for a more rapid and successful extubation. Protocol-based approaches to weaning may have potential benefits in advancing readiness to extubation, but no significant outcome differences have been found to date. The analysis of clinical markers of extubation success has not revealed any specific physiologic predictor of extubation success in children. However, a daily trial of readiness to extubate is the most effective technique to determine likelihood of success. Extubation failure rates range from 16% to 20% and bear little relation to the duration of mechanical ventilation. Upper airway obstruction is the primary cause of extubation failure in most pediatric studies. Therefore, efforts to decrease airway edema before extubation should be considered. Corticosteroids seem to be beneficial for infants and children, but definitive evidence of their efficacy is lacking.
Export Options
About this article
Cite this article as:
Johnston Cintia and Sergio Lucas da Silva Paulo, Weaning and Extubation in Pediatrics, Current Respiratory Medicine Reviews 2012; 8 (1) . https://dx.doi.org/10.2174/157339812798868852
DOI https://dx.doi.org/10.2174/157339812798868852 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Human Model Neurons in Studies of Brain Cell Damage and Neural Repair
Current Molecular Medicine Activin Receptor-Like Kinase 1: a Novel Anti-angiogenesis Target from TGF-β Family
Mini-Reviews in Medicinal Chemistry Membrane Localization of Estrogen Receptors
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Biological Responses to Hydrogen Molecule and its Preventive Effects on Inflammatory Diseases
Current Pharmaceutical Design Current Aspects of Pathophysiology and Cell Dysfunction after Severe Head Injury
Current Pharmaceutical Design The Role of IGF-1 Receptor and Insulin Receptor Signaling for the Pathogenesis of Alzheimers Disease: From Model Organisms to Human Disease
Current Alzheimer Research Natural Substances in the Treatment of Cystic Fibrosis
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) The Rise and Fall of NMDA Antagonists for Ischemic Stroke
Current Molecular Medicine Fenofibrate Increases Heme Oxygenase 1 Expression and Astrocyte Proliferation While Limits Neuronal Injury During Intracerebral Hemorrhage
Current Neurovascular Research Perspectives On Membrane-associated Progesterone Receptors As Prospective Therapeutic Targets
Current Drug Targets Cyclooxygenase Inhibition in Ischemic Brain Injury
Current Pharmaceutical Design Preface: (Commentary on the Special Issue on the Impact of Myogenic Tone in Health and Disease)
Current Vascular Pharmacology Potential Application of 5-Aryl-Substituted 2-Aminobenzamide Type of HDAC1/2- Selective Inhibitors to Pharmaceuticals
Current Pharmaceutical Design Military Risk Factors for Cognitive Decline, Dementia and Alzheimer’s Disease
Current Alzheimer Research Effects of Coenzyme Q and Creatine Supplementation on Brain Energy Metabolism in Rats Exposed to Chronic Cerebral Hypoperfusion
Current Alzheimer Research A Therapeutic Target of Cerebral Hemorrhagic Stroke: Matrix Metalloproteinase- 9
Current Drug Targets Editorial [Hot Topic: Regulation of Brain Functions by Adenosine A2A Receptors:Implication for Therapeutics (Executive Editor: Patrizia Popoli) ]
Current Pharmaceutical Design Antiepileptics for Post-Traumatic Seizure Prophylaxis after Traumatic Brain Injury
Current Pharmaceutical Design Role of Cannabinoids and Endocannabinoids in Cerebral Ischemia
Current Pharmaceutical Design Erythropoietin: New Approaches to Improved Molecular Designs and Therapeutic Alternatives
Current Pharmaceutical Design